Nicholas Alp

Nicholas Alp

Company: Clinical Ink

Job title: Chief Medical Officer

Seminars:

Optimizing Patient Adherence in Clinical Trials: Behavioral Evaluation, Risk Prediction, and Personalized Digital Interventions 12:00 pm

Adherence and retention are critical for clinical trial success. Every participant who discontinues study drug or drops out of a study reduces its statistical power and its credibility SPUR is a unique adherence solution that offers a validated individual behavioral diagnosis and intervention plan for each participant SPUR stands for the 4 key determinants of…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.